Strasbourg-Elsau, France

John R Fozard


Average Co-Inventor Count = 2.4

ph-index = 4

Forward Citations = 62(Granted Patents)


Location History:

  • Strasbourg-Elsau, FR (1984 - 1986)
  • Hegenheim, FR (1991)

Company Filing History:


Years Active: 1984-1991

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of John R Fozard

Introduction

John R Fozard is a notable inventor based in Strasbourg-Elsau, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compositions for treating various medical conditions. With a total of four patents to his name, Fozard's work has had a meaningful impact on pharmaceutical innovations.

Latest Patents

Fozard's latest patents include "Medicament compositions derived from quinolizine and quinolizinone." This invention focuses on the use of esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and hexahydro-8-hydroxy-2,6-methano-2H-quinolizines in the manufacture of a medicament for the treatment of anxiety, psychosis, glaucoma, and for the stimulation of gastric motility. Another significant patent is "Treatment of migraine with substituted tropyl benzoate derivatives," which addresses migraine treatment using a tropyl benzoate derivative of a specific general formula.

Career Highlights

Throughout his career, John R Fozard has worked with prominent companies in the pharmaceutical industry, including Merrell Dow Pharmaceuticals and Merrell Toraude Et Compagnie. His experience in these organizations has contributed to his expertise in developing innovative medicinal solutions.

Collaborations

Fozard has collaborated with notable individuals in his field, including Maurice W Gittos and Francis P Miller. These partnerships have likely enhanced his research and development efforts, leading to successful patent applications.

Conclusion

John R Fozard's contributions to medicinal chemistry and his innovative patents demonstrate his commitment to improving healthcare solutions. His work continues to influence the pharmaceutical industry and offers promising avenues for future research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…